Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu

Erica Giuliani, Lia Vassena, Silvia Galardi, Alessandro Michienzi, Maria Giovanna Desimio, Margherita Doria

Research output: Contribution to journalArticle

Abstract

The HIV-1 accessory protein Vpr displays various activities that can favor viral replication such as G2 cell cycle arrest. Vpr also modulates host gene expression, although this property is poorly characterized. Here, we investigated the effect of Vpr on L-selectin (CD62L), which crucially controls leukocytes circulation and generation of immune responses against pathogens. We report that Vpr up-regulates CD62L mRNA level when individually expressed in Jurkat T cells as well as during HIV-1 infection of primary CD4+ T cells. Vpr mutant analysis and use of inhibitors suggest that the effect of Vpr on CD62L occurs independently of G2 arrest but requires activation of the ATR kinase. Yet, induction of CD62L expression by Vpr is contrasted by down-regulation of CD62L protein by Nef that, together with Vpu, induces a net reduction of cell-surface CD62L on HIV-1-infected cells, which may impact viral spread and evasion of immune responses.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalVirology
Volume523
DOIs
Publication statusPublished - Oct 2018

Fingerprint

L-Selectin
HIV-1
nef Gene Products
G2 Phase Cell Cycle Checkpoints
T-Lymphocytes
Immune Evasion
Jurkat Cells
HIV Infections
Leukocytes
Phosphotransferases
Up-Regulation
Down-Regulation
Gene Expression
Messenger RNA
Human immunodeficiency virus 1 vpr protein

Keywords

  • Ataxia Telangiectasia Mutated Proteins/genetics
  • CD4-Positive T-Lymphocytes/metabolism
  • G2 Phase Cell Cycle Checkpoints/genetics
  • Gene Expression Regulation
  • HIV-1/genetics
  • Histones/genetics
  • Host-Pathogen Interactions
  • Human Immunodeficiency Virus Proteins/genetics
  • Humans
  • Jurkat Cells
  • L-Selectin/genetics
  • Primary Cell Culture
  • RNA, Messenger/genetics
  • Signal Transduction
  • Viral Regulatory and Accessory Proteins/genetics
  • nef Gene Products, Human Immunodeficiency Virus/genetics
  • vif Gene Products, Human Immunodeficiency Virus/genetics
  • vpr Gene Products, Human Immunodeficiency Virus/genetics

Cite this

Dual regulation of L-selectin (CD62L) by HIV-1 : Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu. / Giuliani, Erica; Vassena, Lia; Galardi, Silvia; Michienzi, Alessandro; Desimio, Maria Giovanna; Doria, Margherita.

In: Virology, Vol. 523, 10.2018, p. 121-128.

Research output: Contribution to journalArticle

Giuliani, Erica ; Vassena, Lia ; Galardi, Silvia ; Michienzi, Alessandro ; Desimio, Maria Giovanna ; Doria, Margherita. / Dual regulation of L-selectin (CD62L) by HIV-1 : Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu. In: Virology. 2018 ; Vol. 523. pp. 121-128.
@article{31d41242ed9c47e883446674b6356897,
title = "Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu",
abstract = "The HIV-1 accessory protein Vpr displays various activities that can favor viral replication such as G2 cell cycle arrest. Vpr also modulates host gene expression, although this property is poorly characterized. Here, we investigated the effect of Vpr on L-selectin (CD62L), which crucially controls leukocytes circulation and generation of immune responses against pathogens. We report that Vpr up-regulates CD62L mRNA level when individually expressed in Jurkat T cells as well as during HIV-1 infection of primary CD4+ T cells. Vpr mutant analysis and use of inhibitors suggest that the effect of Vpr on CD62L occurs independently of G2 arrest but requires activation of the ATR kinase. Yet, induction of CD62L expression by Vpr is contrasted by down-regulation of CD62L protein by Nef that, together with Vpu, induces a net reduction of cell-surface CD62L on HIV-1-infected cells, which may impact viral spread and evasion of immune responses.",
keywords = "Ataxia Telangiectasia Mutated Proteins/genetics, CD4-Positive T-Lymphocytes/metabolism, G2 Phase Cell Cycle Checkpoints/genetics, Gene Expression Regulation, HIV-1/genetics, Histones/genetics, Host-Pathogen Interactions, Human Immunodeficiency Virus Proteins/genetics, Humans, Jurkat Cells, L-Selectin/genetics, Primary Cell Culture, RNA, Messenger/genetics, Signal Transduction, Viral Regulatory and Accessory Proteins/genetics, nef Gene Products, Human Immunodeficiency Virus/genetics, vif Gene Products, Human Immunodeficiency Virus/genetics, vpr Gene Products, Human Immunodeficiency Virus/genetics",
author = "Erica Giuliani and Lia Vassena and Silvia Galardi and Alessandro Michienzi and Desimio, {Maria Giovanna} and Margherita Doria",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = "10",
doi = "10.1016/j.virol.2018.07.031",
language = "English",
volume = "523",
pages = "121--128",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Dual regulation of L-selectin (CD62L) by HIV-1

T2 - Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu

AU - Giuliani, Erica

AU - Vassena, Lia

AU - Galardi, Silvia

AU - Michienzi, Alessandro

AU - Desimio, Maria Giovanna

AU - Doria, Margherita

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/10

Y1 - 2018/10

N2 - The HIV-1 accessory protein Vpr displays various activities that can favor viral replication such as G2 cell cycle arrest. Vpr also modulates host gene expression, although this property is poorly characterized. Here, we investigated the effect of Vpr on L-selectin (CD62L), which crucially controls leukocytes circulation and generation of immune responses against pathogens. We report that Vpr up-regulates CD62L mRNA level when individually expressed in Jurkat T cells as well as during HIV-1 infection of primary CD4+ T cells. Vpr mutant analysis and use of inhibitors suggest that the effect of Vpr on CD62L occurs independently of G2 arrest but requires activation of the ATR kinase. Yet, induction of CD62L expression by Vpr is contrasted by down-regulation of CD62L protein by Nef that, together with Vpu, induces a net reduction of cell-surface CD62L on HIV-1-infected cells, which may impact viral spread and evasion of immune responses.

AB - The HIV-1 accessory protein Vpr displays various activities that can favor viral replication such as G2 cell cycle arrest. Vpr also modulates host gene expression, although this property is poorly characterized. Here, we investigated the effect of Vpr on L-selectin (CD62L), which crucially controls leukocytes circulation and generation of immune responses against pathogens. We report that Vpr up-regulates CD62L mRNA level when individually expressed in Jurkat T cells as well as during HIV-1 infection of primary CD4+ T cells. Vpr mutant analysis and use of inhibitors suggest that the effect of Vpr on CD62L occurs independently of G2 arrest but requires activation of the ATR kinase. Yet, induction of CD62L expression by Vpr is contrasted by down-regulation of CD62L protein by Nef that, together with Vpu, induces a net reduction of cell-surface CD62L on HIV-1-infected cells, which may impact viral spread and evasion of immune responses.

KW - Ataxia Telangiectasia Mutated Proteins/genetics

KW - CD4-Positive T-Lymphocytes/metabolism

KW - G2 Phase Cell Cycle Checkpoints/genetics

KW - Gene Expression Regulation

KW - HIV-1/genetics

KW - Histones/genetics

KW - Host-Pathogen Interactions

KW - Human Immunodeficiency Virus Proteins/genetics

KW - Humans

KW - Jurkat Cells

KW - L-Selectin/genetics

KW - Primary Cell Culture

KW - RNA, Messenger/genetics

KW - Signal Transduction

KW - Viral Regulatory and Accessory Proteins/genetics

KW - nef Gene Products, Human Immunodeficiency Virus/genetics

KW - vif Gene Products, Human Immunodeficiency Virus/genetics

KW - vpr Gene Products, Human Immunodeficiency Virus/genetics

U2 - 10.1016/j.virol.2018.07.031

DO - 10.1016/j.virol.2018.07.031

M3 - Article

C2 - 30119013

VL - 523

SP - 121

EP - 128

JO - Virology

JF - Virology

SN - 0042-6822

ER -